Politics Novo Nordisk sues Hims & Hers over compounded obesity drugs Finance News Feb 9, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen,… Read More...
Politics Novo Nordisk stock rises; Hims & Hers pulls copycat weight-loss pill Finance News Feb 9, 2026 Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the… Read More...
Politics Hims & Hers falls 8% after Novo’s legal threat. Here’s the latest Finance News Feb 6, 2026 Rafael Henrique | SOPA Images | APThe stock of Hims & Hers dropped in premarket trading early Friday after a… Read More...
Politics White House launches direct to consumer drug site Finance News Feb 6, 2026 President Donald Trump makes an announcement from the Oval Office at the White House in Washington, Nov. 6,… Read More...
Politics Hims & Hers announces Wegovy pill copy; Novo Nordisk vows legal action Finance News Feb 5, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen,… Read More...
Politics Novo Nordisk stock tumbles after FY earnings, sales forecast Finance News Feb 3, 2026 Novo Nordisk signage on the floor of the New York Stock Exchange in New York, US, on Friday, Jan. 2, 2026.Michael… Read More...
Politics Pfizer’s monthly obesity injection drove shows promise in trial Finance News Feb 3, 2026 Smith Collection | Archive Photos | Getty ImagesPfizer on Tuesday said its experimental obesity drug, which it… Read More...
Politics Merck (MRK) earnings Q4 2025 Finance News Feb 3, 2026 Merck on Tuesday reported fourth-quarter earnings and revenue that topped estimates on strong demand for its cancer… Read More...
Politics Pfizer (PFE) earnings Q4 2025 Finance News Feb 3, 2026 Albert Bourla, CEO of Pfizer, speaking on Squawk on the Street at the World Economic Forum in Davos, Switzerland on… Read More...
Business Eli Lilly CEO David Ricks talks Medicare coverage of obesity pills Finance News Feb 1, 2026 Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the… Read More...